Sign in

CIK 0001279704

  • Non-accelerated filer
  • Smaller reporting company

Cellectar Biosciences, Inc.

Sign in to watch
Ticker
CLRB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
043321804
Phone
+1 608-441-8120
Business address
100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
Former names
NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-07 DRISCOLL FREDERICK W Director Grant or award · Stock option (right to buy) +25,000 25,000
2025-02-14 DRISCOLL FREDERICK W Director Grant or award · Stock option (right to buy) +60,000 60,000
2024-06-14 DRISCOLL FREDERICK W Director Grant or award · Stock option (right to buy) +60,000 60,000
2023-06-28 DRISCOLL FREDERICK W Director Grant or award · Stock option (right to buy) +25,000 47,650
2022-06-24 DRISCOLL FREDERICK W Director Grant or award · Stock option (right to buy) +7,800 7,800
2021-09-03 DRISCOLL FREDERICK W Director Purchase +19,417 $1.04 $20K 19,417
2021-06-30 DRISCOLL FREDERICK W Director Grant or award · Stock option (right to buy) +78,000 78,000
2020-06-24 DRISCOLL FREDERICK W Director Grant or award · Stock option (right to buy) +50,000 50,000
2019-06-13 DRISCOLL FREDERICK W Director Grant or award · Stock option (right to buy) +6,500 6,500
2018-10-12 DRISCOLL FREDERICK W Director Grant or award · Stock option (right to buy) +13,000 13,000
2017-05-31 DRISCOLL FREDERICK W Director Grant or award · Stock option (right to buy) +10,000 10,000

Page 1 of 1 · 11 trades